Metabolomic profile in pregnant women with fetal growth restriction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To search for biomarkers of fetal growth restriction (FGR) based on a study of the metabolic profile of pregnant women. Subjects and methods. Plasma samples from 38 pregnant women were investigated during the study. The pregnant women were divided into two groups: 1) 17 pregnant women with FGR; 2) 21 women with physiological pregnancy. The samples were analyzed using liquid chromatography with mass spectrometric detection. Control of the analysis of experimental results and their processing were done applying Agilent MassHunter software. Results. The investigators identified 18 metabolites min with statistically significantly different levels. Correlation analysis established a signif icant relationship between the identif ied metabolites and clinical and anamnestic data. There was a moderate correlation of FGR with 3 amino acids: beta-alanine (rs = 0.413, p = 0.003), cysteine (rs = 0.588, p <0.001), and ornithine (rs = 0.427, p = 0.002). Conclusion. The findings substantiate the prospects of investigating beta-alanine, cysteine, and ornithine as diagnostic markers of FGR. The high correlation of these metabolites with Doppler readings determines the possibility of their inclusion in the integrated diagnosis of FGR.

Full Text

Restricted Access

About the authors

Natalia E. Kan

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kan-med@mail.ru

Zarine V. Khachatryan

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: z.v.khachatryan@gmail.com

Elrad Yu. Amiraslanov

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: e_amiraslanov@oparina4.ru

V. V Chagovets

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: vvchagovets@gmail.com

Victor L. Tyutyunnik

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: tioutiounnik@mail.ru

Natalia A. Lomova

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: natasha-lomova@yandex.ru

N. L Starodubtseva

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: n_starodubtseva@oparina4.ru

Natalia A. Kitsilovskaya

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: kitsilovskyana@gmail.com

Igor I. Baranov

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: i_baranov@oparina4.ru

Vladimir E. Frankevich

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: v_frankevich@oparina4.ru

References

  1. Вишнякова П.А., Суханова Ю.А., Микаелян А.Г., Булатова Ю.С., Пятаева С.В., Балашов И.С., Боровиков П.И., Тетруашвили Н.К., Высоких М.Ю. Синдром задержки роста плода и маркеры митохондриальной дисфункции. Акушерство и гинекология. 2018; 6: 31-6. doi: 10.18565/aig.2018.6.31-36
  2. Unterscheider J., Daly S., Geary M.P., Kennelly M.M., McAuliffe F.M., O’Donoghue K., et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol. 2013; 208(4): 290.e1-6. doi: 10.1016/j.ajog.2013.02.007
  3. Cruz-Lemini M., Crispi F, Van Mieghem T., Pedraza D., Cruz-Martinez R., Acosta-Rojas R., et al. Risk of perinatal death in early-onset intrauterine growth restriction according to gestational age and cardiovascular Doppler indices: a multicenter study. Fetal Diagn Ther. 2012; 32(1-2): 116-22. doi: 10.1159/000333001.
  4. Balasuriya C.N.D., Stunes A.K., Mosti M.P., Schei B., Indredavik M.S., Hals I.K., et al. Metabolic outcomes in adults born preterm with very low birth weight or small for gestational age at term: a cohort study. J Clin Endocrinol Metab. 2018;103(12): 4437-46. doi: 10.1210/jc.2018-00464
  5. Lee A.C., Kozuki N., Cousens S., Stevens G.A., Blencowe H., Silveira M.F., et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21st standard: analysis of CHERG datasets. BMJ. 2017; 358:j3677. doi: 10.1136/bmj.j3677
  6. Dessi A, Atzori L., Noto A., Visser G.H., Gazzolo D., Zanardo V., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med. 2011; 24 Suppl 2: 35-9. doi: 10.3109/14767058.2011.605868
  7. Dessi A., Marincola F.C., Pattumelli M.G., Ciccarelli S., Corbu S., Ossicini C., et al. Investigation of the 1H-NMR based urine metabolomic profiles of IUGR, LGA and AGA newborns on the first day of life. J Matern Fetal Neonatal Med. 2014; 27 Suppl 2: 13-9. doi: 10.3109/14767058.2014.955674
  8. Barberini L., Noto A., Fattuoni C., Grapov D., Casanova A., Fenu G., et al. Urinary metabolomics (GCMS) reveals that low and high birth weight infants share elevated inositol concentrations at birth. J Matern Fetal Neonatal Med. 2014; 27 Suppl 2: 20-6. doi: 10.3109/14767058.2014.954786
  9. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., et al. HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19): 1991-2002. doi: 10.1056/ NEJMoa0707943
  10. Chau J.F., Lee M.K., Law J.W., Chung S.K., Chung S.S. Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves. FASEB J. 2005; 19(13): 1887-9. doi: 10.1096/fj.05-4192fje
  11. Unfer V., Carlomagno G., Dante G., Facchinetti F. Effects of myo-inositl in women with PCOs: a systematic review of randomized controlled trials. Gynecol Endocrinol. 2012; 28(7): 509-15. doi: 10.3109/09513590.2011.650660
  12. Sant am aria A., Giordano D., Corrado F., Pintaudi B., Interdonato M.L., Vieste G.D., et al. One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric. 2012; 15(5): 490-5. doi: 10.3109/13697137.2011.631063
  13. Maitre L., Fthenou E., Athersuch T., Coen M., Toledano M.B., Holmes E., et al. Urinary metabolic profiles in early pregnancy are associated with preterm birth and fetal growth restriction in the Rhea mother-child cohort study. BMC Med. 2014;12:110. doi: 10.1186/1741-7015-12-110
  14. Favretto D., Cosmi E., Ragazzi E., Visentin S., Tucci M., Fais P., et al. Cord blood metabolomics profiling in intrauterine growth restriction. Anal Bioanal Chem. 2012; 402(3): 1109-21. doi: 10.1007/s00216-011-5540-z
  15. Sanz-Cortes M., Carbajo R.J., Crispi F., Figueras F., Pineda-Lucena A., Gratacos E. Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation. PLoS One. 2013; 8(12): e80121. doi: 10.1371/journal. pone.0080121
  16. Liu J., Chen X.X., Li X.W., Fu W., Zhang W.Q. Metabolomic research on newborn infants with intrauterine growth restriction. Medicine (Baltimore) 2016; 95(17): e3564 doi: 10.1097/MD.0000000000003564
  17. Visentin S., Crotti S., Donazzolo E., D’Aronco S., Nitti D., Cosmi E., et al. Medium chain fatty acids in intrauterine growth restricted and small for gestational age pregnancies. Metabolomics. 2017;13(05):1-9
  18. Lindsay K.L., Hellmuth C., Uhl O., Buss C., Wadhwa P.D., Koletzko B., et al. Longitudinal metabolomics profiling of amino acids and lipids across healthy pregnancy. PLoS One. 2015; 10(12): e0145794. doi: 10.1371/journal. pone.0145794
  19. Leite D., Cecatti J. New Approaches to Fetal Growth Restriction: The Time for Metabolomics Has Come. Rev Bras Ginecol Obstet. 2019; 41(7): 454-62. doi: 10.1055/s-0039-1692126

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Bionika Media